Related Experiment Video

Updated: Apr 27, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

7.7K

Coronary thrombus in patients undergoing primary PCI for STEMI: Prognostic significance and management

Sabine Vecchio1, Elisabetta Varani1, Tania Chechi1

  • 1Sabine Vecchio, Elisabetta Varani, Marco Balducelli, Giuseppe Vecchi, Matteo Aquilina, Giulia Ricci Lucchi, Alessandro Dal Monte, Massimo Margheri, Division of Cardiology, Cardiac Catheterization Laboratory, Santa Maria Delle Croci Hospital, 48121 Ravenna, Italy.

World Journal of Cardiology
|July 1, 2014
PubMed

Insights

Detecting coronary thrombi in acute ST-elevation myocardial infarction (STEMI) indicates a poor prognosis. Managing these thrombi with antithrombotic drugs and thrombectomy is crucial for better patient outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Thrombosis Research

Background:

  • Acute ST-elevation myocardial infarction (STEMI) typically arises from disrupted coronary atherosclerotic plaques and subsequent thrombus formation.
  • Intracoronary thrombi significantly worsen prognosis, impacting both epicardial blood flow and myocardial perfusion.
  • The presence, size, and composition of coronary thrombi are critical prognostic indicators in STEMI.

Purpose of the Study:

  • To review the prognostic significance of intracoronary thrombi in STEMI.
  • To discuss current pharmacological and interventional strategies for managing thrombotic lesions in STEMI patients.

Main Methods:

  • Literature review of studies on intracoronary thrombi in STEMI.
  • Analysis of prognostic implications of thrombus detection.
  • Evaluation of current therapeutic approaches, including antithrombotic drugs and percutaneous thrombectomy.

Main Results:

  • Coronary thrombi are a major adverse prognostic factor in STEMI.
  • Thrombus burden directly correlates with adverse outcomes.
  • Effective management of thrombi is essential for improving angiographical and clinical results.

Conclusions:

  • Primary percutaneous coronary intervention is the standard treatment for STEMI.
  • Adjunctive antithrombotic therapy and/or percutaneous thrombectomy are vital for optimizing STEMI management.
  • Addressing intracoronary thrombi is key to improving treatment efficacy and patient prognosis in STEMI.

Keywords:
Antithrombotic therapiesCoronary thrombectomyIntracoronary thrombosisPrimary percutaneous coronary interventionST-elevation myocardial infarction

More Related Videos

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

11.1K
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

4.9K

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.0K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
493
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
746
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
442
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
919